Comparison of Optimal Hypertension Regimens

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 940 participants.

Also called NCT02847338

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 940 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02847338
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02847338. Randomized; no masking; primary purpose treatment. Start 2016-11 (registry gives no type); primary completion 2023-10 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of Optimal Hypertension Regimens
Acronym
AIMHY-INFORM
Condition
Hypertension
Intervention (Drug)
Amlodipine
Intervention (Drug)
Lisinopril
Intervention (Drug)
Amiloride
Intervention (Drug)
Chlortalidone
Lead sponsor
Cambridge University Hospitals NHS Foundation Trust (class: other)
Collaborator
Medical Research Council (class: other government)

Record details

Record id
cardio:ct-nct02847338
Content hash
8edadee80592fb36a7ed26c307fd048f4faa0b3d291f49c2e5be7ffdf3368a7f